CLARI Share Price Performance
€3.69
-0.22 (-5.72%)
19.0% overvalued intrinsic discount
€3.10
Fair Value
Price €3.69
AnalystLowTarget €3.10
AnalystConsensusTarget €4.53
AnalystHighTarget €5.10
Fair Value€3.10
Share Pricen/a
Clariane SE Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 17 Fair Values set on narratives written by author
CLARI Community Narratives
AN
Fair Value €3.1 19.0% overvalued intrinsic discount
Rising Debt And European Regulation Will Hamper Eldercare
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value €4.53 18.6% undervalued intrinsic discount
Refinancing And French Pricing Will Pressure Margins But Build Resilience
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AN
Fair Value €5.1 27.6% undervalued intrinsic discount
Aging Demographics And Digital Tools Will Fuel Resilient Recovery
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
Aging Demographics And Digital Tools Will Fuel Resilient Recovery
Key Takeaways Portfolio refocusing, operational efficiency gains, and advanced data analytics are set to boost margins, cash flow, and organic earnings growth over the long term. Demographic trends, regulatory advantages, and investment in non-acute care infrastructure position Clariane for sustained market share gains and resilient revenue expansion.Read more
7
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
€5.1
27.6% undervalued intrinsic discount
Fair Value
Revenue
3.29% p.a.
Profit Margin
2.95%
Future PE
14.97x
Price in 2029
€7.21
Rising Debt And European Regulation Will Hamper Eldercare
Key Takeaways High debt levels and rising compliance costs are putting sustained pressure on margins and limiting Clariane's earnings growth potential. Shifts toward home-based senior care and regulatory uncertainty threaten the viability of Clariane's traditional facility-focused business model and revenue stability.Read more
3
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
€3.1
19.0% overvalued intrinsic discount
Fair Value
Revenue
3.12% p.a.
Profit Margin
0.29%
Future PE
92.8x
Price in 2029
€4.38
Refinancing And French Pricing Will Pressure Margins But Build Resilience
Key Takeaways Ongoing disposal plan and deleveraging efforts may limit opportunistic growth and reduce future revenue streams. Margin pressures and refinancing could impact profitability and financial flexibility, constraining revenue and earnings growth.Read more
40
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AN
€4.53
18.6% undervalued intrinsic discount
Fair Value
Revenue
3.96% p.a.
Profit Margin
2.69%
Future PE
14.32x
Price in 2029
€6.4
Trending Discussion
Recently Updated Narratives
AN
CLARI: Higher Margin Focus And Steady Risk Profile Will Support Upside
Fair Value: €5.1 27.6% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
CLARI: Softer Revenue And Margin Pressure Will Strain Elevated Future P/E
Fair Value: €3.1 19.0% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
CLARI: Lower Discount Rate And Margin Outlook Will Support Bullish Momentum
Fair Value: €4.53 18.6% undervalued intrinsic discount
6 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Clariane SE Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Jul 29, 2026
- 0.0045
- 31.16%
- 0.03%
- 98.4%
About CLARI
- Founded
- 2001
- Employees
- 70685
- CEO
- WebsiteView website
Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes. The company also provides inpatient and outpatient services, full-time hospitalization, day hospitalization, and outpatient care, and operates post-acute and rehabilitation care clinics, mental healthcare clinics, and medicine-surgery-obstetrics facilities. In addition, it offers medicalized nursing homes and alternative living solutions, such as shared houses, assisted living, and domiciliary care, as well as outpatient consultations and diagnostics, and social care services. The company was formerly known as Korian and changed its name to Clariane SE in June 2023. Clariane SE was founded in 2001 and is headquartered in Paris, France.
